SUMMARY An immunohistochemical study of 46 B and T cell non-Hodgkin's lymphomas, using monoclonal antibodies to the products of the major histocompatibility complex (MHC) class II antigen subregions, DP, DQ, and DR, showed that most B and T cell lymphomas express these antigens. Both coordinate and non-coordinate expression of MHC class II The aims of this study were to document MHC class II DP, DQ, and DR expression in B and T cell non-Hodgkin's lymphoma and to relate this expression to an index of cellular proliferation measured by flow cytometry.
Material and methods

TISSUES
Forty six biopsy specimens from 45 patients with non-Hodgkin's lymphoma were studied (table 1) .
Accepted for publication 17 July 1986 Cases 3, 1 1, and 12 were of spleen, 4 and 31 of tonsil, 14 of palate, 20 of submandibular salivary gland, and 44 and 45 of skin. The remainder were lymph nodes. Case 32 was from the same subject as biopsy 26 but taken 40 months later. Portions of each specimen were snap frozen in liquid nitrogen and the remainder fixed in 10% formalin and routinely processed to paraffin.
IMMUNOHISTOCHEMISTRY
An indirect immunoperoxidase technique was used on frozen sections 8 pm thick.5 Table 2 lists the monoclonal antibodies used. In addition to those directed against MHC antigens, monoclonal antibodies directed against a wide range of B and T lymphocyte surface membrane antigens were applied to phenotype tumours. Skin sections were incubated with the primary antibody overnight. Other sections were incubated with the primary antibody for one hour. All monoclonal antibodies were used at optimal dilutions derived from titration studies performed on frozen sections of fresh tonsil.
Each MHC class II antigen immunoperoxidase preparation was assessed by a standard procedure. The percentage of positive staining cells was assessed visually and each case was assigned to one of the following grades: grade 0 (0-< 5% cells positive); grade 1 (5-<25% cells positive); grade 2 (25-<50% cells positive); grade 3 (50-<75% cells positive); grade 4 (75-100% cells positive).
Staining of less than 50% of cells (grades 0, 1, and 2) was considered to indicate significantly "reduced expression" of MHC class II antigens, and staining of more than 50% of cells (grades 3 and 4), "strong 34 Thirteen of 36 B cell and four of 10 T cell lymphomas showed non-coordinate expression of DP, DQ, and DR products. Similar proportions of K phenotype (seven of 18 cases) and A phenotype (six of 18 cases) B cell lymphomas showed non-coordinate expression. Cases showing non-coordinate expression occurred in every lymphoma subtype apart from malignant lymphoma immunoblastic, of which there were only two examples. Non-coordinate expression was most common in malignant lymphoma lymphocytic (five of 10 cases), malignant lymphoma lymphoblastic (three of three cases) and mycosis fungoides (two of three cases). There was reduced expression of DP antigen in 17 cases, DQ antigen in 12, and DR antigen in six. All cases showing reduced DR expression also showed reduced DQ and DP expression, and all cases showing reduced DQ expression also showed reduced DP expression. Some cases showed reduced expression of DP alone (table 3) . 38 Smith, Holgate, Williamson, Grigor, Quirke, Bird The mean coefficient of variation of the 32 diploid cases was 8-7%. Table 1 documents the proliferation indices (percentage ofcells in S and G2 phase) of these cases. When the proliferation index was plotted against percentage of DP positive cells (fig 4) no direct relation was observed. Indeed, some tumours with no detectable DP expression had high proliferation indices, and the converse was also true. Plotting proliferation index against DQ and DR expression gave similar results, except that fewer cases showed reduced expression. Statistical analysis of prolif-38 There is evidence to suggest that the interleukin II dependent proliferative response of T lymphocytes requires T cell MHC class II antigen expression25 26 : the proliferation centres of B cell lymphocytic lymphoma show increased mitotic activity and increased MHC class II antigen expression. '7 Finally, it has been suggested that MHC class II antigen expression may be influenced by differences in the proliferative activity of low grade and high grade B cell lymphomas.3 In this study no direct relation between the percentage of lymphoma cells expressing DP, DQ, and DR antigens and the cellular proliferation index assessed by flow cytometry was found. Moreover, no significant relation was established between the proliferation index of cases showing coordinate or non-coordinate expression of MHC class II subregion products. Indeed, a wide range of proliferation indices was seen in both groups, and case 28, with no detectable MHC class II antigen expression, had a proliferation index of 31%. MHC class II antigen expression, therefore, cannot be used as a marker of cellular proliferation.
In conclusion, the results of this study indicate that MHC class II antigen expression in non-Hodgkin's lymphoma does not help to distinguish tumours of B and T cell lineage. Non-coordinate expression of the products of the MHC class II subregions-DP, DQ, and DR-often occurs in non-Hodgkin's lymphoma. Furthermore, the three patterns of non-coordinate expression observed suggest the expression of the subregion products is interdependent. Finally, noncoordinate expression does not show any relation to lymphoma differentiation or to proliferation index.
